Skip to main content
. 2016 Oct 28;22(40):9012–9021. doi: 10.3748/wjg.v22.i40.9012

Table 2.

Other adverse events associated with thioguanine use

Adverse event Prevalence Ref.
GI complaints 1%-17% [16,17,19,20,37,38]
Myelosuppression1 1%-15% [17,20,36,38]
General malaise 4%-22% [17,38]
Allergic reaction 1%-6% [17,33]
Other AE (e.g., myalgia, alopecia) 1%-38% [16,17,19,20,33,36-38]
1

Variable definitions of myelosuppression were applied.